{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T03:01:01Z","timestamp":1772938861226,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11845-025-04157-2","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T10:45:56Z","timestamp":1762771556000},"page":"363-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The cure hit a nerve: a case of immune checkpoint inhibitor-induced mononeuritis multiplex"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2490-1660","authenticated-orcid":false,"given":"Aine","family":"Redmond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Foley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Beausang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany","family":"El Naggar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick Glyn","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarushka","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuala","family":"McNicholas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"9","key":"4157_CR1","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.7150\/jca.57334","volume":"12","author":"C Ghosh","year":"2021","unstructured":"Ghosh C, Luong G, Sun Y (2021) A snapshot of the PD-1\/PD-L1 pathway. J Cancer 12(9):2735","journal-title":"J Cancer"},{"issue":"5","key":"4157_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.neurol.2023.03.003","volume":"179","author":"A Farina","year":"2023","unstructured":"Farina A, Villagr\u00e1n-Garc\u00eda M, Honnorat J (2023) Neurological adverse events of immune checkpoint inhibitors: an update of clinical presentations, diagnosis, and management. Rev Neurol 179(5):506\u2013515","journal-title":"Rev Neurol"},{"issue":"11","key":"4157_CR3","doi-asserted-by":"publisher","first-page":"e1093","DOI":"10.1212\/WNL.0000000000008091","volume":"93","author":"D Dubey","year":"2019","unstructured":"Dubey D, David WS, Amato AA, Reynolds KL, Clement NF, Chute DF, Cohen JV, Lawrence DP, Mooradian MJ, Sullivan RJ, Guidon AC (2019) Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies. Neurology 93(11):e1093\u2013e1103","journal-title":"Neurology"},{"issue":"11","key":"4157_CR4","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.3390\/jcm8111777","volume":"8","author":"N M\u00f6hn","year":"2019","unstructured":"M\u00f6hn N, Beutel G, Gutzmer R, Ivanyi P, Satzger I, Skripuletz T (2019) Neurological immune related adverse events associated with nivolumab, ipilimumab, and pembrolizumab therapy\u2014review of the literature and future outlook. J Clin Med 8(11):1777","journal-title":"J Clin Med"},{"issue":"4","key":"4157_CR5","doi-asserted-by":"publisher","first-page":"e993","DOI":"10.1212\/NXI.0000000000000993","volume":"8","author":"MC Baldauf","year":"2021","unstructured":"Baldauf MC, Kapauer M, Joerger M, Flatz L, Rodriguez R, Frank S, Felbecker A, Hartmann-Fussenegger S, Hundsberger T (2021) Pembrolizumab-associated CD8 + vasculitic mononeuritis multiplex in a patient with mesothelioma. Neurol Neuroimmunol Neuroinflamm 8(4):e993","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"4157_CR6","first-page":"1093858","volume":"2017","author":"K Sakai","year":"2017","unstructured":"Sakai K, Mochizuki H, Mochida K, Shiomi K, Amano M, Nakazato M (2017) A case of Nivolumab-Induced severe mononeuropathy multiplex and rhabdomyolysis. Case Rep Med 2017(1):1093858","journal-title":"Case Rep Med"},{"issue":"1","key":"4157_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13256-022-03290-1","volume":"16","author":"S Abdelhakim","year":"2022","unstructured":"Abdelhakim S, Klapholz JD, Roy B, Weiss SA, McGuone D, Corbin ZA (2022) Mononeuritis multiplex as a rare and severe neurological complication of immune checkpoint inhibitors: a case report. J Med Case Rep 16(1):81","journal-title":"J Med Case Rep"},{"key":"4157_CR8","doi-asserted-by":"crossref","unstructured":"Haanen JB, Carbonnel F, Robert C, Kerr KM, Peters S, Larkin J, Jordan K (2020) Management of toxicities from immunotherapy. ESMO Clin Pract Guid Diagn Treat Follow-up 2018:29","DOI":"10.1093\/annonc\/mdy162"},{"key":"4157_CR9","doi-asserted-by":"crossref","unstructured":"Idogun PO, Hafez-Khayyata S, Ezekwudo D (2024) Immune checkpoint inhibitor-induced guillain barre syndrome: a single-institution case report and narrative review. Cureus 16(6)","DOI":"10.7759\/cureus.61489"},{"key":"4157_CR10","doi-asserted-by":"publisher","first-page":"1338899","DOI":"10.3389\/fneur.2024.1338899","volume":"15","author":"A Farina","year":"2024","unstructured":"Farina A, Escalere M, Dion M, Moussy M, Pegat A, Villagr\u00e1n-Garc\u00eda M, Devic P, Lamiral A, Seyve A, Aure K, Wang A, Gorza L, Streichenberger N, Maisonobe T, Honnorat J, Birzu C, Psimaras D, Weisenburger-Lile D, Joubert B (2024) Mononeuritis multiplex following immune checkpoint inhibitors in malignant pleural mesothelioma. Front Neurol 15:1338899. https:\/\/doi.org\/10.3389\/fneur.2024.1338899PMID: 38333608; PMCID: PMC10850347","journal-title":"Front Neurol"},{"key":"4157_CR11","doi-asserted-by":"crossref","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D et al (2013) The CARE guidelines: consensus-based clinical case reporting guideline development. Case Reports 2013:bcr2013201554. Available from: https:\/\/casereports.bmj.com\/content\/2013\/bcr-2013-201554","DOI":"10.1136\/bcr-2013-201554"},{"key":"4157_CR12","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D et al (2025) The CARE reporting checklist. In: Harwood J, Albury C, Beyer J de, Schl\u00fcssel M, Collins G, editors. The EQUATOR network reporting guideline platform [Internet]. The UK EQUATOR Centre; Available from: https:\/resources.equator-network.org\/reporting-guidelines\/care\/care-checklist.docx"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-025-04157-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T09:14:41Z","timestamp":1772874881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-025-04157-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4157"],"URL":"https:\/\/doi.org\/10.1007\/s11845-025-04157-2","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The participant has consented to the submission of the case report to the journal.Ethics approval was not required for this case report per institutional protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u00a0The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}]}}